AdvaMed - Advanced Medical Technology Association
01/07/2025 | Press release | Distributed by Public on 01/07/2025 12:56
Francis Medical Announces Close of Record $80 Million Series C Equity Financing
Press Releases
Francis Medical Announces Close of Record $80 Million Series C Equity Financing
- PR Newswire
- January 7, 2025
Funding will continue supporting VAPOR 2 pivotal clinical study and U.S. commercialization of Vanquish Water Vapor Ablation proprietary prostate cancer treatment
MINNEAPOLIS, January 7, 2025 / - Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today announced the completion of the company's oversubscribed $80 million Series C equity financing, the largest fundraising round to date for the company.
Read more.
Share this article:
Call to Action…
AdvaMed - Advanced Medical Technology Association published this content on January 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 07, 2025 at 18:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]